## Background Epidermal Growth Factor Receptor (EGFR) is a key target molecule in current treatment of several neoplastic diseases. Hence, in order to develop and improve current drugs targeting EGFR signalling, an accurate understanding of how this signalling pathway is regulated is required. It h
β¦ LIBER β¦
Progressive arthropathy in mice with a targeted disruption of the Mop3/Bmal-1 locus
β Scribed by Maureen K. Bunger; Jacqueline A. Walisser; Ruth Sullivan; Paul A. Manley; Susan M. Moran; Vicki L. Kalscheur; Ricki J. Colman; Christopher A. Bradfield
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 666 KB
- Volume
- 41
- Category
- Article
- ISSN
- 1526-954X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Epidermal growth factor receptor levels
β
Morten P Oksvold; Ane Funderud; Anne-Katrine Kvissel; Ellen Skarpen; Heidi Henan
π
Article
π
2008
π
BioMed Central
π
English
β 818 KB
Selective protection against oxidative d
β
Juan Carlos MartΓnez-Lazcano; Francisca PΓ©rez-Severiano; Bruno Escalante; Joel R
π
Article
π
2007
π
John Wiley and Sons
π
English
β 555 KB
## Abstract Nitric oxide (NO) is an essential messenger molecule in brain, where it is produced in neurons mostly by the activity of the neuronal isoform of nitric oxide synthase (nNOS). To understand the participation of the different isoforms of NOS in physiological functioning and in pathologica
Targeted disruption of Col11a2 produces
β
Shi-Wu Li; Masamine Takanosu; Machiko Arita; Yunhua Bao; Zhao-Xia Ren; Alfred Ma
π
Article
π
2001
π
John Wiley and Sons
π
English
β 908 KB